Human Herpesvirus Type 6 Indirectly Enhances Oligodendrocyte Cell Death

References

• Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B, Salahuddin SZ, Gallo RC (1991). Ge-nomic polymorphism, growth properties, and immuno-logic variations in human herpesvirus-6 isolates. Virol-ogy 184: 545–552.
   PubMed Web of Science ®Google Scholar
• Ablashi DV, Lapps W, Kaplan M, Whitman JE, Richert JR, Pearson GR (1998). Human Herpesvirus-6 (HHV-6) in-fection in multiple sclerosis: a preliminary report. MuIt Scler 4: 490–496.
   PubMed Web of Science ®Google Scholar
• Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, Jacobson S (2000). Tissue dis-tribution and variant characterization of human her-pesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 182: 1321–1325.
   PubMed Web of Science ®Google Scholar
• Alvarez-Lafuente R, Martin-Estefania C, de Las Heras V, Castillo C, Picazo JJ, Varela de Seijas E, Gonzalez RA(2002). Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch Neurol 59: 929–933.
   Google Scholar
• Aubin JT, Collandre H, Candotti D, Ingrand D, Rouzioux C, Burgard M, Richard S, Huraux JM, Agut H (1991). Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbic)] 29: 367–372.
   PubMed Web of Science ®Google Scholar
• Berti R, Soldan SS, Akhyani N, McFarland HF, Jacobson S (2000). Extended observations on the association of HHV-6 and multiple sclerosis. I NeuroVirol 6 (Suppl 2): S85–S87.
   Google Scholar
• Black J, Sanderlin K, Goldsmith C, Gary H, Lopez C, Pellett P (1989). Growth properties of human herpesvirus-6 strain Z29. J Virol Methods 26: 133–145.
   PubMed Web of Science ®Google Scholar
• Blumberg BM, Mock DJ, Powers JM, Ito M, Assouline JG, Baker JV, Chen B, Goodman AD (2000). The HHV6 paradox: ubiquitous commensal or insidious pathogen?A two-step in situ PCR approach. J Clin Virol 16: 159–178.
   PubMedGoogle Scholar
• Campadelli-Fiume G, Mirandola P, Menotti L (1999). Hu-man herpesvirus 6: an emerging pathogen. Emerg Infect Dis 5: 353–366.
   PubMed Web of Science ®Google Scholar
• Cermelli C, Berti R, Soldan SS, Mayne M, D'Ambrosia JM, Ludwin SK, Jacobson S (2003). High frequency of hu-man herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. I Infect Dis 187: 1377–1387.
   Google Scholar
• Cermelli C, Jacobson S (2000). Viruses and multiple scle-rosis. Viral Immunol 13: 255–267.
   PubMed Web of Science ®Google Scholar
• Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, et al (1995). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Nati Acad Sci US A 92: 7440–7444.
   PubMed Web of Science ®Google Scholar
• Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces tumor necrosis factor-a production: implications for HIV-1 associated neurological diseases. J Biol Chem 272: 22385–22388.
   PubMed Web of Science ®Google Scholar
• Clark DA (2000). Human herpesvirus 6. Rev Med Virol 10: 155–173.
   PubMed Web of Science ®Google Scholar
• Cohen SA, Michaud DP (1993). Synthesis of a fluo-rescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal Biochem 211: 279–287.
   PubMed Web of Science ®Google Scholar
• Corley SM, Ladiwala U, Besson A, Yong VW (2001). Astrocytes attenuate oligodendrocyte death in vitro through an alpha(6) integrin-laminin-dependent mech-anism. Glia 36: 281–294.
   PubMed Web of Science ®Google Scholar
• Di Luca D, Mirandola P, Ravaioli T, Bigoni B, Cassai E (1996). Distribution of HHV-6 variants in human tissues. Infect Agents Dis 5: 203–214.
   Google Scholar
• Diemel LT, Copelman CA, Cuzner ML (1998). Macrophages in CNS remyelination: friend or foe? Neurochem Res 23: 341–347.
   Google Scholar
• D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP (1996). Multiple scle-rosis: Fas signaling in oligodendrocyte cell death. I Exp Med 184: 2361–2370.
   PubMed Web of Science ®Google Scholar
• Enbom M, Wang FZ, Fredrikson S, Martin C, Dahl H, Linde A (1999). Similar humoral and cellular immunological reactivities to human herpesvirus 6 inpatients with mul-tiple sclerosis and controls. Clin Diagn Lab Immunol 6: 545–549.
   PubMedGoogle Scholar
• Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J (1995). Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 85: 1263–1271.
   PubMedGoogle Scholar
• Follett PL, Rosenberg PA, Volpe JJ, Jensen FE (2000). NBQX attenuates excitotoxic injury in developing white matter. I Neurosci 20: 9235–9241.
   Google Scholar
• Friedman JE, Lyons MJ, Cu G, Ablashl DV, Whitman JE, Edgar M, Koskiniemi M, Vaheri A, Zabriskie JB (1999). The association of the human herpesvirus-6 and MS. Mult Scler 5: 355–362.
   PubMed Web of Science ®Google Scholar
• Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM (2003). Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 187: 1365–1376.
   PubMed Web of Science ®Google Scholar
• Grivel JC, Ito Y, Faga G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P, Margolis L (2001). Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med 7: 1232-1235.
   Google Scholar
• Gutierrez J, Vergara MJ, Guerrero M, Fernandez O, Piedrola G, Morales P, Maroto MC (2002). Multiple sclerosis and human herpesvirus 6. Infection 30: 145–149.
   Google Scholar
• Hall CB, Caserta MT, Schnabel KC, Long C, Epstein LG, Insel RA, Dewhurst S (1998). Persistence of human her-pesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 26: 132–137.
   PubMed Web of Science ®Google Scholar
• Horvat RT, Parmely MJ, Chandran B (1993). Human her-pesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J Infect Dis 167: 1274–1280.
   Google Scholar
• Kim JS, Lee KS, Park JH, Kim MY, Shin WS (2000). De-tection of human herpesvirus 6 variant A in periph-eral blood mononuclear cells from multiple sclerosis pa-tients. Eur Neurol 43: 170–173.
   PubMed Web of Science ®Google Scholar
• Lassmann H (1998). Neuropathology in multiple sclerosis: new concepts. Mult Scler 4: 93–98.
   Google Scholar
• Levine JM, Reynolds R, Fawcett JW (2001). The oligoden-drocyte precursor cell in health and disease. Trends Neurosci 24: 39–47.
   PubMed Web of Science ®Google Scholar
• Ludwin SK (1996). The reactions of the oligodendrocyte. Mult Scler 2: 241–243.
   Google Scholar
• Ludwin SK (1997). The pathobiology of the oligodendro-cyte. J Neuropathol Exp Neurol 56: 111–124.
   PubMed Web of Science ®Google Scholar
• Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, Sanchez-Gomez MV (2001). The link be-tween excitotoxic oligodendroglial death and demyeli-nating diseases. Trends Neurosci 24: 224–230.
   Google Scholar
• Mayne M, Cheadle C, Soldan SS, Cermelli C, Yamano Y, Akhyani N, Nagel JE, Taub DD, Becker KG, Jacobson S (2001). Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J Virol 75: 11641–11650.
   PubMed Web of Science ®Google Scholar
• McLaurin J, Trudel GC, Shaw IT, Antel JP, Cashman NR (1995). A human glial hybrid cell line differentially ex-pressing genes subserving oligodendrocyte and astro-cyte phenotype. I Neurobiol 26: 283–293.
   Google Scholar
• Nitsche A, Muller CW, Radonic A, Landt O, Ellerbrok H, Pauli G, Siegert W (2001). Human herpesvirus 6A DNA is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow trans-plantation. /Infect Dis 183: 130–133.
   Google Scholar
• Ongradi J, Rajda C, Marodi CL, Csiszar A, Vecsei L (1999). A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. I NeuroVirol 5: 529–532.
   Google Scholar
• Otero GC, Merrill JE (1997). Response of human oligoden-drocytes to interleukin-2. Brain Behav Immun 11: 24–38.
   Google Scholar
• Pellett PE, Sanchez-Martinez D, Dominguez G, Black JB, Anton E, Greenamoyer C, Dambaugh TR (1993). A strongly immunoreactive virion protein of human her-pesvirus 6 variant B strain Z29: identification and char-acterization of the gene and mapping of a variant-specific monoclonal antibody reactive epitope. Virology 195: 521–531.
   PubMed Web of Science ®Google Scholar
• Pitt D, Werner P, Raine CS (2000). Glutamate excitotoxicity in a model of multiple sclerosis [see comments]. Nat Med 6: 67–70.
   PubMed Web of Science ®Google Scholar
• Pouly S, Antel JP (1999). Multiple sclerosis and central ner-vous system demyelination. J Autoimmun 13: 297–306.
   Google Scholar
• Roffman E, Albert JP, Goff JP, Frenkel N (1990). Putative site for the acquisition of human herpesvirus 6 virion tegument. J Virol 64: 6308–6313.
   Google Scholar
• Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al (1986). Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596–601.
   PubMed Web of Science ®Google Scholar
• Sanders VJ, Felisan S, Waddell A, Tourtellotte WW (1996). Detection of herpesviridae in postmortem multiple scle-rosis brain tissue and controls by polymerase chain re-action. J NeuroVirol 2:249–258.
   PubMed Web of Science ®Google Scholar
• Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G, Taniguchi T, Fukui T, Kasuga N, Aono T, Sako M, Hara J, Yamanishi K, Okada S (2002). High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100: 2005–2011.
   PubMed Web of Science ®Google Scholar
• Selmaj K, Raine CS, Cannella B, Brosnan CF (1991). Iden-tification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949–954.
   PubMed Web of Science ®Google Scholar
• Selmaj KW, Raine CS (1988). Tumor necrosis factor medi-ates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346.
   PubMed Web of Science ®Google Scholar
• Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S (1997). Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and de-tection of serum HHV-6 DNA. Nat Med 3: 1394–1397.
   PubMed Web of Science ®Google Scholar
• Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S (2000). Increased lymphoproliferative response to hu-man herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 47: 306–313.
   PubMed Web of Science ®Google Scholar
• Soldan SS, Jacobson S (2001). Role of viruses in etiology and pathogenesis of multiple sclerosis. In: Advances in virus research. Buchmeier M, Campbell I (eds). San Diego: Academic Press, pp 511–552.
   Google Scholar
• Strydom DJ, Cohen SA (1994). Comparison of aminoacid analyses by phenylisothiocyanateand 6- aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization. Anal Biochem 222: 19–28.
   PubMed Web of Science ®Google Scholar
• Taus C, Pucci E, Cartechini E, Fie A, Giuliani G, Clementi M, Menzo S (2000). Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple scle-rosis. Acta Neurol Scand 101: 224–228.
   PubMedGoogle Scholar
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ (2002). Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol 76: 6147–6154.
   Google Scholar
• Uesugi H, Shimizu H, Maehara T, Arai N, Nakayama H (2000). Presence of human herpesvirus 6 and her-pes simplex virus detected by polymerase chain reaction in surgical tissue from temporal lobe epileptic patients. Psychiatry Clin Neurosci 54: 589–593.
   Google Scholar
• Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE, Morgan MA, Hulette C, Kurtzberg J, Bushnell C, Epstein L, Lewis DV (2001). Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 50: 612–619.
   Google Scholar
• Werner P, Pitt D, Raine CS (2000). Glutamate excitotoxicity-a mechanism for axonal damage and oligodendrocyte death in multiple sclerosis? J Neural Transm Suppl 60: 375–385.
   Google Scholar
• Werner P, Pitt D, Raine CS (2001). Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligo-dendrocyte and axonal damage. Ann Neurol 50: 169–180.
   PubMed Web of Science ®Google Scholar
• Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T (1988). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065–1067.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Asano Y (2000). Central nervous system com-plications in human herpesvirus-6 infection. Brain Dev 22: 307–314.
   PubMed Web of Science ®Google Scholar